Dr. Deana M. Lazaro, M.D.

Media Releases

Leading Rheumatologist Spearheading Advanced Training Program and Enhancing Patient Care for Veterans

A respected rheumatologist, Dr. Lazaro is the Director of the esteemed Rheumatology Fellowship Program at SUNY Downstate Medical Center in Brooklyn, New York, and Chief of Rheumatology Section at The VA New York Harbor Healthcare System.

In her role as the Director of the Rheumatology Fellowship Program, she leads efforts to provide advanced training to the next generation of rheumatologists. By mentoring fellows and facilitating research opportunities, she aims to foster excellence in patient care and contribute to the advancement of rheumatology as a specialty.

Educated in the United States, Dr. Lazaro received her Bachelor of Science degree from Seton Hall University and her medical degree from the New York University School of Medicine. She completed her post-graduate training with distinction, including a residency in internal medicine at Thomas Jefferson University Hospital, a Chief Residency at Morristown Memorial Hospital, and a fellowship in rheumatology at UMDNJ-New Jersey Medical School.

Distinguished as a Fellow of the American College of Rheumatology, the doctor is board-certified in both internal medicine and rheumatology by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world. 

A keen researcher, her research interests encompass a wide range of topics, with a particular focus on the epidemiology of systemic lupus erythematosus and its correlation with cardiovascular outcomes. She is also committed to improving the healthcare outcomes of veterans with rheumatic diseases, a population that she serves with great compassion and expertise.

Recommended Articles

• Lyme Disease: Making a Diagnosis

  Lyme disease is an infectious disease caused by four different species of bacteria. In Europe and Asia, it spreads through Borrelia afzelii and Borrelia garinii, while in the USA, it spreads through Borrelia burgdorferi and Borrelia mayonii. The disease is transmitted to humans via a common...

• New Genetic Markers for Lupus Identified in Multi-Ethnic Study

  Lupus is an autoimmune disease that has struck an estimated 2 million Americans according to the Lupus Foundation of America. Around the world, lupus has already struck a total of 5 million people, and 90% of them are all women commonly between 15 to 45. Lupus has the chance to be life threatening...

• Understanding the Causes of Fibromyalgia

  The exact cause of fibromyalgia is a medical mystery; however, research on this condition and pain and sensory processing is being monitored to discover how fibromyalgia develops and impacts the body. For now, research has identified several risk factors that predispose an individual for developing...

• Can Melatonin Help Fibromyalgia Patients?

  Melatonin is mostly used as a sleeping pill, but several studies show that melatonin can help in preventing fibromyalgia pain. People with fibromyalgia can suffer from pain in various parts of the body. Common pain occurs in the shoulders, arms, neck, hips, back, and legs. Aside from pain and...

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) for Fibromyalgia

  What is Fibromyalgia?Fibromyalgia is a chronic medical condition that is associated with pain spread widely through various parts of the body, such as the bones and muscles. The symptoms are very subjective, which means that they cannot be determined easily with physical examination, even with...

• New FDA Approved Drug for Lupus

  Over time FDA approves some drugs to be used to treat different diseases. Almost every month new drugs are approved. There are a lot of research happening at the moment, and usually, most of these research lead to the development of better medications. There are new products that FDA approved in...